Either the lipid phosphatase MTMR2 or its regulatory binding partner, MTMR13/SBF2, has been related to the demyelinating peripheral neuropathy CMT disease type 4B (CMT4B) (14). Here, SBF2 is linked to demyelinating polyneuropathy.